Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses

被引：0
|
作者：
Ni Sima
Rong Li
Wei Huang
Miao Xu
Jeanette Beers
Jizhong Zou
Steven Titus
Elizabeth A. Ottinger
Juan J. Marugan
Xing Xie
Wei Zheng
机构：
[1] National Institutes of Health,National Center for Advancing Translational Sciences
[2] Women’s Reproductive Health Laboratory of Zhejiang Province,Department of Gynecologic Oncology
[3] Women’s Hospital,iPSC core, National Heart
[4] School of Medicine,undefined
[5] Zhejiang University,undefined
[6] Lung and Blood Institute,undefined
[7] National Institutes of Health,undefined
来源：
Orphanet Journal of Rare Diseases | / 13卷
关键词：
Neuronal ceroid lipofuscinosis; INCL; LINCL; Lysosomal storage disease; Induced pluripotent stem cells; Neural stem cells; Enzyme replacement therapy; Cyclodextrin; δ-tocopherol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis
    Tracy, Christopher J.
    Whiting, Rebecca E. H.
    Pearce, Jacqueline W.
    Williamson, Baye G.
    Vansteenkiste, Daniella P.
    Gillespie, Lauren E.
    Castaner, Leilani J.
    Bryan, Jeffrey N.
    Coates, Joan R.
    Jensen, Cheryl A.
    Katz, Martin L.
    EXPERIMENTAL EYE RESEARCH, 2016, 152 : 77 - 87
  • [42] Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency
    Kalviainen, R.
    Eriksson, K.
    Losekoot, M.
    Sorri, I.
    Harvima, I.
    Santavuori, P.
    Jarvela, I.
    Autti, T.
    Vanninen, R.
    Salmenpera, T.
    van Diggelen, O. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (04) : 369 - 372
  • [43] Enzyme Replacement Therapy Attenuates Disease Progression in a Canine Model of Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
    Katz, Martin L.
    Coates, Joan R.
    Sibigtroth, Christine M.
    Taylor, Jacob D.
    Carpentier, Melissa
    Young, Whitney M.
    Wininger, Fred A.
    Kennedy, Derek
    Vuillemenot, Brian R.
    O'Neill, Charles A.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (11) : 1591 - 1598
  • [44] Normal blood TPP1 enzyme levels and classical late infantile onset neuronal ceroid lipofuscinosis (Batten disease)
    Williams, RE
    Hughes, E
    Fensom, A
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 : 16 - 17
  • [45] Neuronal ceroid lipofuscinosis (NCL) types 1 and 2: Enzyme characteristics of PPT1 and TPP1, and their high risk and newborn screenings
    Itagaki, Rina
    Endo, Masahiro
    Yanagisawa, Hiroko
    Hossain, Mohammad Arif
    Akiyama, Keiko
    Miyajima, Takashi
    Wu, Chen
    Iwamoto, Takeo
    Igarashi, Junko
    Shintaku, Haruo
    Eto, Yoshikatsu
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S78 - S78
  • [46] Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study
    Nickel, Miriam
    Simonati, Alessandro
    Jacoby, David
    Lezius, Susanne
    Kilian, Dirk
    Van de Graaf, Benjamin
    Pagovich, Odelya E.
    Kosofsky, Barry
    Yohay, Kaleb
    Downs, Matthew
    Slasor, Peter
    Aiayi, Temitayo
    Crystal, Ronald G.
    Kohlschuetter, Alfried
    Sondhi, Dolan
    Schulz, Angela
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (08): : 582 - 590
  • [47] Molecular basis of CLN2 disease: A review and classification of TPP1 gene variants reported worldwide
    Mole, Sara E.
    Gardner, Emily
    Schulz, Angela
    Xin, Winnie W.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S97 - S97
  • [48] Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)
    Miriam Sindelar
    Jonathan P. Dyke
    Ruba S. Deeb
    Dolan Sondhi
    Stephen M. Kaminsky
    Barry E. Kosofsky
    Douglas J. Ballon
    Ronald G. Crystal
    Steven S. Gross
    Scientific Reports, 8
  • [49] Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)
    Sindelar, Miriam
    Dyke, Jonathan P.
    Deeb, Ruba S.
    Sondhi, Dolan
    Kaminsky, Stephen M.
    Kosofsky, Barry E.
    Ballon, Douglas J.
    Crystal, Ronald G.
    Gross, Steven S.
    SCIENTIFIC REPORTS, 2018, 8
  • [50] Additive Effects of Intrathecal and Intravenous Combination Dosing of CLN1 Gene Therapy in the Mouse Model of Infantile Neuronal Ceroid Lipofuscinosis
    Rozenberg, Alejandra J.
    Lykken, Erik A.
    Gray, Steven J.
    MOLECULAR THERAPY, 2018, 26 (05) : 256 - 256
12345